NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,247 Cr | ₹1,189 Cr | ₹856 Cr | ₹621 Cr | ₹413 Cr |
What is the latest Sundry Debtors ratio of NATCO PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹1,247 Cr |
Mar2024 | ₹1,189 Cr |
Mar2023 | ₹856 Cr |
Mar2022 | ₹621 Cr |
Mar2021 | ₹413 Cr |
How is Sundry Debtors of NATCO PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹1,247 Cr | 4.85 | |
Mar2024 | ₹1,189 Cr | 38.87 | |
Mar2023 | ₹856 Cr | 37.95 | |
Mar2022 | ₹621 Cr | 50.30 | |
Mar2021 | ₹413 Cr | - |
Compare Sundry Debtors of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,137.5 Cr | -1.3% | -7% | -46.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -1.3% |
-7% |
-46.1% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses